Abciximab
| Use attributes for filter ! | |
| CAS ID | 143653-53-6 |
|---|---|
| Formula | C2101H3229N551O673S15 |
| Molar mass | 47455. 4 g/mol g·mol−1 |
| Trade name | Reopro |
| Elimination half-life | <10 min–30 min |
| Source | Chimeric (mouse/human) |
| Target | CD41 |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951048 |
About Abciximab
Abciximab or Abcixifiban, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor . . .